All regulations
Nonrulemaking
FDA
FDA-2024-E-1293
Patent Term Extension Application for ZELSUVMI™ (berdazimer sodium), Patent No. 9,855,211
Documents
6
Comments
1
Key Dates
Comment Period OpensMar 18, 2024
Comment Period ClosesFeb 28, 2026
Documents
| Type | Title | Status |
|---|---|---|
Notice |
Comment Statistics
Total Comments
1
Keywords
CDER
Patent Term Extension Application for ZELSUVMI
berdazimer sodium
Patent No. 9,855,211
OPEN
Data from Regulations.gov